Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes

NCT01812811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2013-12-11

No results posted yet for this study

Summary

The functionality and reproducibility of pulse wave analysis is investigated in 20 type 2 diabetic patients who had two 24 hour measurements performed within one week with the Arteriograph24 equipment.

Conditions

Sponsors & Collaborators

  • Regionshospitalet Silkeborg

    collaborator OTHER
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Klavs W Hansen, MD, dr.med. · Medical department, Diagnostic Center, Regional Hospital Silkeborg, Denmark

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812811 on ClinicalTrials.gov